US stocks: Fulcrum shares plummet over 50% after scrapping lead sickle-cell drug on FDA concerns
The oral drug, pociredir, was being tested to treat sickle-cell disease, an inherited blood disorder that can trigger pain, anemia and organ damage and reduce life expectancy.
The Economic Times ·